Business Context and Reporting Period
This Form 8-K filing by TriplePoint Venture Growth BDC Corp. (TPVG) reports a material event occurring on December 9, 2022. The Company is a business development company focused on venture growth investments.
Key Financial Metrics and Material Changes
The filing details a significant credit event involving a borrower, Medly Health Inc. ("Medly"), which filed for Chapter 11 bankruptcy protection. Key financial impacts include:
- Non-Accrual Status: TPVG placed its investments in Medly on non-accrual status effective October 1, 2022.
- Expected Write-Down: The Company expects to fully write down the fair value of its investments in Medly, excluding a new debtor-in-possession (DIP) facility.
- Credit Rating: TPVG expects to assign Medly a rating of 5 under its credit watch list.
- New Lending Activity: TPVG and its affiliates are providing a DIP credit facility to Medly. TPVG's portion is up to approximately $3.4 million, which will be senior to Medly's pre-bankruptcy debt.
- Recovery Outlook: The amount of recovery on existing investments is currently not determinable.
The filing does not provide consolidated revenue, profit, cash flow, or total debt figures for the Company as a whole.
Management Commentary and Risks
Management notes that Medly's bankruptcy was precipitated by adverse developments, liquidity issues, loss of anticipated financing, and the discovery of operational, financial, and accounting irregularities by former employees and founders. Medly is seeking court approval to sell assets, including its Pharmaca line of business, in which TPVG holds a non-controlling economic interest. The Company is actively monitoring the bankruptcy proceedings to evaluate future recovery potential.
Investor Verification Checklist
- Verify the total exposure amount of TPVG's pre-bankruptcy investments in Medly Health Inc.
- Confirm the specific terms and seniority of the $3.4 million debtor-in-possession facility.
- Monitor the progress of Medly's asset sales, specifically the Pharmaca line of business.
- Review upcoming quarterly reports for the actual recognition of the expected write-down and its impact on net asset value.